GlassScriptPhysician profile
Alan M Askinas
NPI 1962483883
$1,256.38
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $129 · 2021: $276 · 2022: $57.30 · 2023: $348 · 2024: $37.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $291.28 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.59 | 2023 | |
| Abbvie INC. | $145.80 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $93.65 | 2023-2024 | Veozah |
| Allergan, INC. | $83.79 | 2019-2020 | |
| Duchesnay USA Incorporated | $71.18 | 2019-2020 | |
| Coopersurgical, INC. | $63.95 | 2019-2023 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $47.55 | 2019 | |
| Therapeuticsmd, INC. | $37.67 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $26.47 | 2019-2020 | |
| Mission Pharmacal Company | $25.29 | 2019-2020 | |
| Myovant Sciences INC. | $22.34 | 2022 | |
| Medtronic, INC. | $21.26 | 2021 | |
| Lupin INC. | $20.32 | 2019 | |
| Mayne Pharma Commercial LLC | $19.98 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $15.91 | 2019 | |
| Exeltis, USA INC. | $15.76 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.62 | 2020 | |
| Baxter Healthcare | $14.00 | 2019 | |
| Sumitomo Pharma America, INC. | $14.00 | 2023 | Myfembree |
| Medtronic Minimed, INC. | $13.72 | 2019 | |
| Amgen INC. | $11.22 | 2019 | |
| Pfizer INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Askinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.